March 7th, 2022
Effective March 2nd, 2022, Canadian Hospital Specialties Limited (CHS) is pleased to announce the acquisition of OralDent Pharma Inc. (“OralDent.”)
The acquisition of OralDent will broaden CHS' footprint in the Dental Market within the non-acute channel. OralDent’s PerioPlus® professional mouthwashes are uniquely formulated to target a variety of oral conditions and maintain healthy hygiene. This acquisition builds on CHS’ rapidly expanding presence in the non-acute channel while looking to grow into Pharmacy, Homecare, and Long-term Care channels.
CHS welcomes the new OralDent team members, and we look forward to providing high quality products and exceptional service to our customers in the future.